Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
LHA serves multiple roles in acne management
Paris - A new cosmetic product incorporating beta-lipohydroxyacid (LHA), a lipophilic derivative of salicylic acid, appears to be usefulwhen used alone for preventing relapses in patients who have responded toacne treatment and as an adjunct to topical tretinoin for improving thetolerability of the retinoid and shortening the onset to efficacy, accordingto results of prospective, randomized, double-blind studies presented byBrigitte Dréno, M.D., at the World Congress of Dermatology.
Related Videos
Related Content
